American Society for Microbiology, Journal of Clinical Microbiology, 7(50), p. 2513-2514, 2012
DOI: 10.1128/jcm.00590-12
Full text: Download
ABSTRACT Vancomycin-intermediate resistance has not been previously reported among sequence type 72 (ST72) methicillin-resistant Staphylococcus aureus (MRSA) isolates of SCC mec type IV (ST72-MRSA-IV), which are distinctive community genotype strains in Korea. We report the first case of vancomycin treatment failure due to development of vancomycin-intermediate resistance in infection caused by an ST72-MRSA-IV isolate.